A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma.

1 According to the International Agency for Research on Cancer (IARC), there were an estimated 133,354 new cases of NPC and 80,008 NPC-related deaths in 2020 worldwide, showing an increasing trend compared with 2018. 2 , 3 As a country with the highest incidence rate of NPC in the world, in 2018, the corresponding new cases of NPC and NPC-related deaths in China were as high as 60, 558 and 31, 413 respectively, and most of which were confirmed to be locoregionally advanced (LA) NPC at the ti

also in 63,971 other papers